Independent Franchise Partners LLP Johnson & Johnson Transaction History

Independent Franchise Partners LLP

$9.6 Billion
Q2 2024

A detailed history of Independent Franchise Partners LLP transactions in Johnson & Johnson stock. As of the latest transaction made, Independent Franchise Partners LLP holds 3,862,080 shares of JNJ stock, worth $605 Million. This represents 5.88% of its overall portfolio holdings.

Number of Shares

3,862,080

Previous 4,050,492 4.65%

Holding current value

$605 Million

Previous $641 Million 11.9%

% of portfolio

5.88%

Previous 5.96%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $27.2 Million - $29.7 Million	-188,412 Reduced 4.65%	3,862,080 $564 Million
Q1 2024 May 14, 2024	BUY	$155.22 - $162.74 $271 Million - $284 Million	1,747,672 Added 75.89%	4,050,492 $641 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $16.6 Million - $18.1 Million	-114,192 Reduced 4.72%	2,302,820 $361 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $2.83 Million - $3.17 Million	-18,181 Reduced 0.75%	2,417,012 $376 Million
Q2 2023 Aug 11, 2023	BUY	$154.35 - $166.11 $925,173 - $995,663	5,994 Added 0.25%	2,435,193 $403 Million
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $1.29 Million - $1.53 Million	-8,515 Reduced 0.35%	2,429,199 $377 Million
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $7.05 Million - $7.91 Million	-43,999 Reduced 1.77%	2,437,714 $431 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $67 Million - $74.6 Million	-415,417 Reduced 14.34%	2,481,713 $405 Million
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $52.8 Million - $58.4 Million	-313,950 Reduced 9.78%	2,897,130 $514 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $24.7 Million - $28.1 Million	-156,454 Reduced 4.65%	3,211,080 $569 Million
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $5.91 Million - $6.56 Million	-37,904 Reduced 1.11%	3,367,534 $576 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $37.3 Million - $41.5 Million	-231,039 Reduced 6.35%	3,405,438 $550 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $40.6 Million - $43.6 Million	-254,846 Reduced 6.55%	3,636,477 $599 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $12.9 Million - $14.3 Million	84,078 Added 2.21%	3,891,323 $640 Million
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $12.9 Million - $14.8 Million	93,999 Added 2.53%	3,807,245 $599 Million
Q3 2020 Nov 13, 2020	SELL	$140.38 - $153.83 $203 Million - $223 Million	-1,448,582 Reduced 28.06%	3,713,246 $553 Million
Q2 2020 Aug 13, 2020	BUY	$128.81 - $155.51 $6.28 Million - $7.58 Million	48,763 Added 0.95%	5,161,828 $726 Million
Q1 2020 May 14, 2020	SELL	$111.14 - $153.99 $12.4 Million - $17.2 Million	-111,569 Reduced 2.14%	5,113,065 $670 Million
Q4 2019 Feb 13, 2020	SELL	$127.5 - $146.44 $105 Million - $121 Million	-823,804 Reduced 13.62%	5,224,634 $762 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $96.2 Million - $108 Million	-758,149 Reduced 11.14%	6,048,438 $783 Million
Q2 2019 Aug 13, 2019	SELL	$131.15 - $144.24 $133 Million - $146 Million	-1,012,412 Reduced 12.95%	6,806,587 $948 Million
Q1 2019 May 14, 2019	SELL	$125.72 - $139.79 $9.8 Million - $10.9 Million	-77,932 Reduced 0.99%	7,818,999 $1.09 Billion
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $104 Million - $126 Million	-849,132 Reduced 9.71%	7,896,931 $1.02 Billion
Q3 2018 Nov 13, 2018	BUY	$121.58 - $142.88 $235 Million - $276 Million	1,931,673 Added 28.35%	8,746,063 $1.21 Billion
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $48.1 Million - $53.1 Million	403,223 Added 6.29%	6,814,390 $827 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $3.51 Million - $4.16 Million	28,075 Added 0.44%	6,411,167 $822 Million
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $5.91 Million - $6.47 Million	-45,063 Reduced 0.7%	6,383,092 $892 Million
Q3 2017 Oct 23, 2017	BUY	$129.47 - $135.38 $832 Million - $870 Million	6,428,155	6,428,155 $836 Million

Others Institutions Holding JNJ

# of Institutions

4,227

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Franchise Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Independent Franchise Partners LLP with notifications on news.

Account

Independent Franchise Partners LLP Johnson & Johnson Transaction History